Philadelphia, PA (Oct. 5, 2020) – In new , the Ñî¹óåú´«Ã½ (ACP) says that evidence points toward a net benefit with the use of remdesivir for patients with COVID-19. Should Remdesivir Be Used for the Treatment of Patients with COVID-19? Rapid, Living Practice Points from the Ñî¹óåú´«Ã½ (Version 1) was published today in Annals of Internal Medicine.
Statement attributable to:
Jacqueline W. Fincher, MD, MACP
President, Ñî¹óåú´«Ã½
ACP is pleased to announce that the Board of Regents has approved the following individuals and institutions to receive College awards and Mastership.
Washington, DC (September 15, 2020) — Today the Ñî¹óåú´«Ã½ (ACP) released a new policy paper focused on increasing competition in the marketplace and addressing anticompetitive behaviors to combat the rising costs of prescription drugs. The new paper titled , is the third installment of a series published in Annals of Internal Medicine.
Washington, DC (September 11, 2020) — Today the Ñî¹óåú´«Ã½ (ACP) sent a letter to every member of Congress stressing the importance that the planned increases in payments for evaluation and management (E/M) services and other changes to the Medicare Physician Fee Schedule move forward as scheduled on Jan. 1.
